During the past decade, Ahmed Farahat conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ahmed Farahat" are "Overactive Bladder" (1 trials) and "Spastic Neurogenic Bladder" (1 trials). Many other conditions were trialed in "Ahmed Farahat" in a lesser frequency.

Most popular intervention types in "Ahmed Farahat" are "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "intradetrusor injection of botulinumtoxinA (Botox)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ahmed Farahat" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Ahmed Farahat". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Ahmed Farahat, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ahmed Farahat, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".